The Neocell Collagen Group, an Australian biotech company with a range of products, including a new collagen-derived protein, has announced that it has raised $12 million in a new round led by investment firm Firstmark Capital.
The funding will allow the company to focus on building out its supply chain and ramp up production of its protein-rich protein collagen.
The $12m in new funding comes after the company raised a Series A round led in part by former Google co-founder Sergey Brin.
The company is looking to scale up production to 10% of its current capacity in 2021.
Neocell has a product called Neocell CEL, which is derived from the Neocell protein.
NeoCell says that its CEL is the first protein derived from collagen.
It is a natural and natural-like protein that can be derived from any type of protein.
The new round will help the company increase its protein production capacity to 10%.
The company says that it will invest in expanding its research and development facilities to support growth.
Neocells main product is the NeoCell CEL.
NeoCells latest collagen product, Neocell GEL, is another collagen product.
Neo cells protein has been the target of intense scrutiny over the past year and has attracted considerable attention because it is derived mainly from a synthetic source.
Neo cell claims that it is the only protein that is derived entirely from the human body.
In the past few years, NeoCell has grown into a leader in the field of collagen synthesis and has made significant progress in the process, according to a Neocell statement.
Neo Cell has a range, and has products that include NeoCell GEL collagen, NeoCEL protein, NeoGEL collagen and NeoGels protein.
It has also invested in the development of an advanced polymer and new formulations, as well as in the manufacture of its proprietary collagen.
Neocel has announced several products over the years, including Neocell Pro Gel, Neocel Pro and Neocell Ultra Gel.
Neoceliase, the company’s second product, is the latest product from Neocell, a protein that has been shown to improve blood flow to the body.
It also offers an alternative to the common diet of eating a lot of carbs.
Neo CELL and NeoCell are both based in Adelaide, Australia.
NeoCELL was founded in 2007 by the former chief executive of the Australian Biotech and Biomedical Innovation Research Centre, the body that has led the research and commercialisation of Neocell products since it was founded by the late Andrew Wightman in 2005.
Neo CEL was first launched in 2011 and is currently the second most popular collagen product in Australia.
A NeoCell spokesperson said that Neocell is currently in the early stages of expanding its product range.
It will be focussing on increasing the quantity and quality of NeoCEL and is working with other suppliers to ramp up the production of Neo CEL to meet growing demand.
The spokesperson said: “Our aim is to increase the number of products available, which will ultimately enable us to meet the needs of our customers, as we build on our existing production capabilities and ramp-up production capabilities.”
Neo CEEL and NeoCEll have also launched their NeoCel Protein, which has been designed to be more widely available than NeoCEOL.
The NeoCEEL protein is designed to treat and prevent inflammation, according the NeoCEELL spokesperson.
NeoCC is a private company that was formed in 2010 by former Australian government scientists, who said that the company could provide a better understanding of how the human immune system responds to disease.
Neo-cell also has a line of NeoCell collagen products, which are used in the production and testing of products in the medical and pharmaceutical industries.
NeoCTA, NeoCT, NeoCEIL, NeoCC and NeoCC are trademarks of Neo Cell Limited.